Christian O Henry Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Christian O Henry is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 24,310 shares of DNA, which is worth approximately $269,111. The most recent transaction as insider was on Sep 09, 2025, when has been sold 10,000 shares (Class A Common Stock) at a price of $11.06 per share, resulting in proceeds of $110,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.3K

45.14% 3M change

98.19% 12M change

Total Value Held $269,111

CHRISTIAN O HENRY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2025	SELL Open market or private sale	$110,600 $11.06 p/Share	10,000 Reduced 29.15%	24,310 Class A Common Stock
Sep 08 2025	SELL Open market or private sale	$109,200 $10.92 p/Share	10,000 Reduced 22.57%	34,310 Class A Common Stock
Jun 11 2025	BUY Exercise of conversion of derivative security	-	10,822 Added 19.63%	44,310 Class A Common Stock
Jun 12 2024	BUY Exercise of conversion of derivative security	-	105,263 Added 7.29%	1,339,641 Class A Common Stock
Nov 02 2023	SELL Open market or private sale	$6,255 $1.39 p/Share	4,500 Reduced 0.36%	1,234,378 Class A Common Stock
Oct 02 2023	SELL Open market or private sale	$20,241,001 $4499.0 p/Share	4,499 Reduced 0.36%	1,238,878 Class A Common Stock
Sep 05 2023	SELL Open market or private sale	$10,032 $2.23 p/Share	4,499 Reduced 0.36%	1,243,377 Class A Common Stock
Aug 02 2023	SELL Open market or private sale	$10,122 $2.25 p/Share	4,499 Reduced 0.36%	1,247,876 Class A Common Stock
Jul 03 2023	SELL Open market or private sale	$8,503 $1.89 p/Share	4,499 Reduced 0.36%	1,252,375 Class A Common Stock
Jun 12 2023	SELL Open market or private sale	$71,772 $1.84 p/Share	39,007 Reduced 3.01%	1,256,874 Class A Common Stock
Jun 02 2023	SELL Open market or private sale	$7,333 $1.63 p/Share	4,499 Reduced 0.35%	1,295,881 Class A Common Stock
May 02 2023	SELL Open market or private sale	$5,218 $1.16 p/Share	4,499 Reduced 0.34%	1,300,380 Class A Common Stock
Apr 03 2023	SELL Open market or private sale	$5,938 $1.32 p/Share	4,499 Reduced 0.34%	1,304,879 Class A Common Stock
Mar 14 2023	SELL Open market or private sale	$6,163 $1.37 p/Share	4,499 Reduced 0.34%	1,309,378 Class A Common Stock
Feb 02 2023	SELL Open market or private sale	$9,447 $2.1 p/Share	4,499 Reduced 0.34%	1,313,877 Class A Common Stock
Jan 04 2023	SELL Open market or private sale	$7,063 $1.57 p/Share	4,499 Reduced 0.34%	1,318,376 Class A Common Stock
Dec 02 2022	SELL Open market or private sale	$8,323 $1.85 p/Share	4,499 Reduced 0.34%	1,322,875 Class A Common Stock
Nov 03 2022	SELL Open market or private sale	$126,694 $2.56 p/Share	49,490 Reduced 3.59%	1,327,374 Class A Common Stock
Jun 10 2022	BUY Grant, award, or other acquisition	-	70,921 Added 4.9%	1,376,864 Class A Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	-	1,071,395 Added 45.07%	1,305,943 Class A Common Stock
Sep 16 2021	BUY Grant, award, or other acquisition	-	234,548 Added 50.0%	234,548 Class A Common Stock

Also insider at

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare

Officer

WVE

Wave Life Sciences Ltd. Healthcare

COH